Ayrton Capital LLC - 31 Mar 2025 SCHEDULE 13G Report for ReShape Lifesciences Inc. Common stock, par value $0.001 per share (RSLS)

Filing Manager
Ayrton Capital LLC
Reporting Manager
Ayrton Capital LLC
Security
ReShape Lifesciences Inc. Common stock, par value $0.001 per share
Symbol
RSLS
Shares outstanding
3.5M shares
Disclosed Ownership
200K shares
Ownership
5.71%
Form type
SCHEDULE 13G
Filing time
14 May 2025, 14:59:01 UTC
Date of event
31 Mar 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Ayrton Capital LLC 5.71% 200K 200K 0 /s/ Waqas Khatri Waqas Khatri / Managing Member
Alto Opportunity Master Fund, SPC - Segregated Master Portfolio B 5.71% 200K 200K 0 /s/ Waqas Khatri Waqas Khatri / Director
Waqas Khatri 5.71% 200K 200K 0 /s/ Waqas Khatri Waqas Khatri